Last reviewed · How we verify

NCT05117580: METSZI

Telemedicine With Metabolic Syndrome

Status unknown NA Last updated 11 November 2021
What this trial tests

NA trial testing telemedicine lifestyle guidance in Metabolic Syndrome in 130 participants. Status unknown.

Timeline
1 July 2021
Primary endpoint
28 February 2022
28 February 2022

Quick facts

Lead sponsorSzeged University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposehealth services research
Enrollment130
Start date1 July 2021
Primary completion28 February 2022
Estimated completion28 February 2022
Sites1 location across Hungary

Drugs / interventions tested

Conditions studied

Sponsor

Szeged University

Who can join

Adults 18 to 75, any sex, with Metabolic Syndrome or Life Style. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Investigation of the effect of a 3-month telemedicine-led lifestyle intervention on cardiovascular risk factors, functional indicators, in patients with metabolic syndrome.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Metabolic Syndrome

Currently open trials in the same condition.

Other Szeged University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05117580.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing